Project Title: Challenging African Swine Fever outbreaks with innovative VLP-based vaccines” (ASF-INNOVAC)
Funding: EUROSTARS 2
Project Nr.: E!114258
Period: 36 months 01.10.2020.-30.09.2023.
Project funding: EUR 210 000.00
Partners: HypoPet, The Institute of Virology and Immunology, BISC Global
Coordinator: Martin Bachmann (HypoPet)
BMC Principle Investigator: Dr. biol. K.Tārs
The overall aim of ASF-INNOVAC is to to develop a safe and efficacious vaccine for ASF through VLPs based on antigens predicted by smart algorithms, constitutes such an innovative approach.
Information published: 01.10.2020.